Biotech

All Articles

Ideaya bags choice on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on stopped working epilepsy medicine, boasts FDA run

.We actually understand that Takeda is actually wishing to find a course to the FDA for epilepsy med...

VBI Vaccinations apply for bankruptcy, seeks resource purchase

.Immunology biotech VBI Vaccinations is actually veering dangerously near to the moment of truth, al...

Celldex anti-cKIT antitoxin lessen colonies in one more stage 2 research study

.It's hard to muscular tissue in on a space as competitive as immunology, but Celldex Therapeutics b...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics and also a preclinical imm...

Ventyx's last hope for inflamed med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's ailment medicine carried out not assist patients accomplish remission i...

Cognition's phase 2 sparkle information tarnish Alzheimer's prospect

.Cognition Therapeutics' stage 2 SHINE test has taken a number of the appeal off the Alzheimer's con...

BMS axes bispecific months after filing to work period 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., that managed Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers Squi...

Asarina to close after attempts to companion Tourette's medication stop working

.After communicating to much more than 200 providers to partner a Tourette syndrome therapy that rev...